FNCT Biotech
Latest round
- Series B
Last raised
- Jun 2026
Total raised
- $18M
Investors
- 12
About FNCT Biotech
Based in Seoul, South Korea, and founded in 2021 by co-founders Jin-woo Jin and Su-Jae Lee, FNCT Biotech, Inc. operates as a provider of research and development services for drugs and cures for cancer and fibrosis. In June 2026, FNCT Biotech, Inc. FNCT Biotech, Inc. is developing Pulmonary fibrosis, which is a medical treatment for lung fibrosis and cancer targeting. The company offers biotechnology for research and development of the antibody for treating cancer.
Who invested in FNCT Biotech
12 investors across 2 rounds
See all investors in FNCT Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about FNCT Biotech
Who invested in FNCT Biotech?
FNCT Biotech has 12 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has FNCT Biotech raised?
FNCT Biotech has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did FNCT Biotech last raise money?
FNCT Biotech's most recent round on record is a Series B, in Jun 2026.
What does FNCT Biotech do?
Based in Seoul, South Korea, and founded in 2021 by co-founders Jin-woo Jin and Su-Jae Lee, FNCT Biotech, Inc.
Where is FNCT Biotech headquartered?
FNCT Biotech is headquartered in Seongnam, South Korea.
Which VCs invest in companies like FNCT Biotech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at FNCT Biotech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like FNCT Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.